- ALDX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Aldeyra Therapeutics (ALDX) 8-K2 Mar 23Planned U.S. Launch of ADX-2191 in Second Half of 2023, Pending Approval by the FDAFinancial data
Company Profile